These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 36835194)

  • 1. The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation.
    Galzitskaya OV; Grishin SY; Glyakina AV; Dovidchenko NV; Konstantinova AV; Kravchenko SV; Surin AK
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein.
    Jia L; Wang W; Yan Y; Hu R; Sang J; Zhao W; Wang Y; Wei W; Cui W; Yang G; Lu F; Zheng J; Liu F
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31182-31194. PubMed ID: 32584021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
    Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous Human Proteins Interfering with Amyloid Formation.
    Gharibyan AL; Wasana Jayaweera S; Lehmann M; Anan I; Olofsson A
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
    Mahakud AK; Shaikh J; Rifa Iqbal VV; Gupta A; Tiwari A; Saleem M
    J Membr Biol; 2022 Dec; 255(6):705-722. PubMed ID: 35670831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo designed protein inhibitors of amyloid aggregation and seeding.
    Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence and structure-based peptides as potent amyloid inhibitors: A review.
    Mitra A; Sarkar N
    Arch Biochem Biophys; 2020 Nov; 695():108614. PubMed ID: 33010227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery.
    Di Scala C; Armstrong N; Chahinian H; Chabrière E; Fantini J; Yahi N
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Amyloid Protein Aggregation Using Selected Peptidomimetics.
    Maity D
    ChemMedChem; 2023 Jan; 18(2):e202200499. PubMed ID: 36317359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
    Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the Role of Lipids in the Aggregation of Amyloidogenic Proteins.
    Kurouski D
    Acc Chem Res; 2023 Nov; 56(21):2898-2906. PubMed ID: 37824095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides.
    Kumar D; Kumar P
    Neuropeptides; 2019 Dec; 78():101971. PubMed ID: 31540705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
    Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
    Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amyloid state of proteins: A boon or bane?
    Hassan MN; Nabi F; Khan AN; Hussain M; Siddiqui WA; Uversky VN; Khan RH
    Int J Biol Macromol; 2022 Mar; 200():593-617. PubMed ID: 35074333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.
    Lashuel HA; Grillo-Bosch D
    Methods Mol Biol; 2005; 299():19-33. PubMed ID: 15980593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.